These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37837335)

  • 1. Aptamer-modified tetrahedral DNA nanostructure-immobilized liposome for specific gene delivery and potential cancer theragnostic.
    Lim DY; Hwang BH
    Biotechnol J; 2024 Jan; 19(1):e2300156. PubMed ID: 37837335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy.
    Zhao R; Bai Y; Guo Y; Feng F; Shuang S
    Macromol Biosci; 2024 Apr; 24(4):e2300420. PubMed ID: 38088938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer.
    Wang N; Yu C; Xu T; Yao D; Zhu L; Shen Z; Huang X
    J Nanobiotechnology; 2022 Nov; 20(1):486. PubMed ID: 36403038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
    Esawi E; Alshaer W; Mahmoud IS; Alqudah DA; Azab B; Awidi A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
    Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer.
    Li X; Wu X; Yang H; Li L; Ye Z; Rao Y
    Biomed Pharmacother; 2019 Sep; 117():109072. PubMed ID: 31202169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells.
    Zhou Y; Yang Q; Wang F; Zhou Z; Xu J; Cheng S; Cheng Y
    Int J Nanomedicine; 2021; 16():1805-1817. PubMed ID: 33692623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on Sgc8 aptamer-mediated nucleic acid nanomaterial-doxorubicin complex for tumor targeted therapy.
    Hu X; Zhang J; Xiang Q; Huang G; Yuan Q; Wang Y; Shen Z
    Eur J Pharm Biopharm; 2023 May; 186():7-17. PubMed ID: 36858245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
    Lohlamoh W; Soontornworajit B; Rotkrua P
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-Modified Tetrahedral DNA Nanostructure for Tumor-Targeted Drug Delivery.
    Li Q; Zhao D; Shao X; Lin S; Xie X; Liu M; Ma W; Shi S; Lin Y
    ACS Appl Mater Interfaces; 2017 Oct; 9(42):36695-36701. PubMed ID: 28991436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.
    Yaghoobi E; Zavvar T; Ramezani M; Alibolandi M; Rahimzadeh Oskuei S; Zahiri M; Alinezhad Nameghi M; Abnous K; Taghdisi SM
    J Drug Target; 2022 Dec; 30(10):1106-1112. PubMed ID: 35736221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting drug delivery and efficient lysosomal escape for chemo-photodynamic cancer therapy by a peptide/DNA nanocomplex.
    Wang Q; He Z; Zhu H; Gao W; Zhang N; Li J; Yan J; He B; Ye X
    J Mater Chem B; 2022 Jan; 10(3):438-449. PubMed ID: 34951442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours.
    Liu M; Ma W; Li Q; Zhao D; Shao X; Huang Q; Hao L; Lin Y
    Cell Prolif; 2019 Jan; 52(1):e12511. PubMed ID: 30311693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery.
    Leach JC; Wang A; Ye K; Jin S
    Int J Mol Sci; 2016 Mar; 17(3):380. PubMed ID: 26985893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.